Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Namibia has been increasing steadily over the years.
Customer preferences: Namibians are becoming more health-conscious and are prioritizing preventative healthcare measures. As a result, there has been an increasing demand for vaccines, especially for diseases such as measles, polio, and hepatitis. Additionally, the government of Namibia has been actively promoting vaccination programs to increase the vaccination rate in the country.
Trends in the market: The vaccines market in Namibia has been growing due to the increasing demand for vaccines. The market is dominated by multinational pharmaceutical companies that have a strong presence in the country. These companies have been expanding their product portfolios to cater to the growing demand for vaccines. Additionally, the government has been partnering with these companies to provide vaccines to the population.
Local special circumstances: Namibia has a high burden of infectious diseases such as malaria and HIV/AIDS. The government has been actively working to combat these diseases through vaccination programs. Additionally, the country has a young population, with a median age of 22 years, which makes vaccination programs crucial in preventing the spread of diseases.
Underlying macroeconomic factors: Namibia has a small population of approximately 2.5 million people, which limits the size of the vaccines market. However, the country has a stable political environment and a growing economy, which has led to an increase in healthcare spending. This has resulted in increased funding for vaccination programs and an increase in the demand for vaccines. The government has also been working to improve the healthcare infrastructure in the country, which has made it easier to distribute vaccines to the population.In conclusion, the vaccines market in Namibia has been growing due to the increasing demand for vaccines, the government's efforts to promote vaccination programs, and the country's stable political environment and growing economy. The market is dominated by multinational pharmaceutical companies, and the demand for vaccines is driven by the high burden of infectious diseases in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
